Perspectives from recent advances of Helicobacter pylori vaccines research
Ying Zhang,Xiaoya Li,Baoen Shan,Hongtao Zhang,Lianmei Zhao
DOI: https://doi.org/10.1111/hel.12926
Helicobacter
Abstract:Background: Helicobacter pylori (H. pylori) infection is the main factor leading to some gastric diseases. Currently, H. pylori infection is primarily treated with antibiotics. However, with the widespread application of antibiotics, H. pylori resistance to antibiotics has also gradually increased year by year. Vaccines may be an alternative solution to clear H. pylori. Aims: By reviewing the recent progress on H. pylori vaccines, we expected it to lead to more research efforts to accelerate breakthroughs in this field. Materials & methods: We searched the research on H. pylori vaccine in recent years through PubMed®, and then classified and summarized these studies. Results: The study of the pathogenic mechanism of H. pylori has led to the development of vaccines using some antigens, such as urease, catalase, and heat shock protein (Hsp). Based on these antigens, whole-cell, subunit, nucleic acid, vector, and H. pylori exosome vaccines have been tested. Discussion: At present, researchers have developed many types of vaccines, such as whole cell vaccines, subunit vaccines, vector vaccines, etc. However, although some of these vaccines induced protective immunity in mouse models, only a few were able to move into human trials. We propose that mRNA vaccine may play an important role in preventing or treating H. pylori infection. The current study shows that we have developed various types of vaccines based on the virulence factors of H. pylori. However, only a few vaccines have entered human clinical trials. In order to improve the efficacy of vaccines, it is necessary to enhance T-cell immunity. Conclusion: We should fully understand the pathogenic mechanism of H. pylori and find its core antigen as a vaccine target.